Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Clin Immunol. 2017 Apr 18;180:69–79. doi: 10.1016/j.clim.2017.04.006

Figure 4.

Figure 4

Bar graph showing representation (percentage) of the combined rs2234358 (designated 358) and rs2234355 (designated 355) genotypes in the Healthy controls (HCs), viraemic controllers (VCs) and progressors (A). The three highlighted (grey shading) genotypes are the combined genotypes that are distinctly differentially represented in VCs compared to both HCs and progressors. (B) Comparison of the rs2234358-TT, rs2234355-GA as well as the combination of the absence of rs2234358-TT and the presence of rs2234355-GA (-358TT/+355GA) between VCs and HCs and progressors showing Bonferroni corrected P values for the comparisons (Pbonf). Significant P values (P<0.05) are shown in bold text.